Tensions run high in OK opioid trial Thursday; State focuses on risk data J&J relied on

Opioids | May 31, 2019

NORMAN, Okla. (Legal Newsline) - Tensions ran high in court Thursday as the Oklahoma opioid trial continued, with defense attorney Larry Ottoway objecting throughout the day to opposing counsel's line of questioning directed at defense witness, business director for Janssen Pharmaceuticals Kimberly Deem-Eshleman.

Smaller crowd on hand second day of Oklahoma opioid trial; Father of OD victim testifies

Opioids | May 30, 2019

NORMAN, Okla. (Legal Newsline) - Cleveland County District Judge Thad Balkman overruled several objections made by Johnson & Johnson/Janssen Pharmaceuticals (J&J) as the second day of trial unfolded in the state's pursuit of abatement in what it calls a man-made opioid crisis.

Father recounts loss of son in Oklahoma Johnson & Johnson opioid trial

Opioids | May 30, 2019

NORMAN, Okla. (Legal Newsline) – Fighting back tears, a father who lost his son to an opioid overdose recounted the nightmare during testimony in a trial alleging that Johnson & Johnson flooded the state with addictive drugs for profit.

Hunter: Case is about abating 'worst' man-made crisis; J&J: Case is about damages - not abatement

Opioids | May 29, 2019

NORMAN, Okla. (Legal Newsline) - Admitting there is a high potential for abuse in opioid medications, Johnson & Johnson attorney Larry Ottaway said during opening arguments on Tuesday that physicians prescribing its medications Nucynta and Duragesic know this risk and have to know it to be licensed.

Opening remarks in opioid case against Johnson & Johnson alleges greed created drug epidemic

Opioids | May 28, 2019

NORMAN, Okla. (Legal Newsline) – Opening arguments began Tuesday in a first-ever trial in attempt to hold drug manufacturers accountable for an opioid over-dose crisis, accusing Johnson & Johnson and its subsidiary company Janssen Pharmaceuticals of providing medications for profit that destroyed thousands of lives.